
MYELOMA EURONET The voice of myeloma patients in Europe
Last modified: 06 April 2010
Treatment with interferon
Alpha-interferon is an active substance produced by the body that acts on the cells of the immune system. Amongst other things inferon inhibits the reproduction of plasma cells. Experience has shown that the use of inferon is to be recommended with patients for whom chemotherapy has led to a remission, or at least to a stabilising of the clinical picture. This particularly concerns high dosage therapy and stem cell transplantation patients. The aim of inferon therapy is to maintain the remission achieved through chemotherapy.
Influenza-like symptoms and episodes of depression are possible side effects.

Our Memberships and Collaborations on European Level


Top of page